Cannabis concentrates

Search documents
Investing in Cannabis: The Top 3 U.S. Marijuana Stocks for August 2025
Marijuana Stocks | Cannabis Investments And News. Roots Of A Budding Industry.™· 2025-08-21 14:00
In August 2025, three U.S. marijuana stocks stand out. Trulieve Cannabis Corp., Glass House Brands Inc., and Verano Holdings Corp. each demonstrate competitive advantages in scale, operations, and financial positioning. These companies also remain well-positioned for potential benefits from regulatory reform. Therefore, they deserve attention from investors seeking exposure to a recovering sector. Let's examine their retail networks, dispensary counts, and recent financial performance to understand why they ...
MediPharm Labs Positioned for Unique Opportunities on Possible Rescheduling of Cannabis in the United States
Prnewswire· 2025-08-13 11:30
MediPharm Labs holds unique US Food and Drug Administration (FDA) site registration in relation to the manufacturing and release of pharmaceutical cannabis products. MediPharm is the only US FDA Audited purpose-built commercial cannabis facility in Canada. One of a handful globally. The possible rescheduling of cannabis in the US opens new opportunities for MediPharm in categories where the Company maintains a competitive advantage.TORONTO, Aug. 13, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (O ...
LEEF Brands Announces Successful Completion of Acquisition of its New York License
Globenewswire· 2025-06-09 13:00
Core Insights - LEEF Brands Inc. is expanding nationally by acquiring a Type 1 Cannabis Processor License in New York, marking a significant milestone for the company [2][4] - The New York cannabis market has seen rapid growth, projected to reach $1.5 billion in retail sales in 2025, presenting a substantial opportunity for LEEF to leverage its extraction capabilities [3] Company Developments - The acquisition of the Type 1 Cannabis Processor License allows LEEF to engage in extraction, blending, infusion, packaging, labeling, and branding of its products, positioning it as a multi-state operator [2][3] - LEEF plans to replicate its successful California operations in New York, tailored to meet the specific demands of the local market [3][4] Market Context - The New York cannabis retail market grew from $160 million in 2023 to $1 billion in 2024, indicating a strong upward trend [3] - Concentrates account for approximately 55% of cannabis products sold in New York, highlighting the potential for LEEF's extraction capabilities to support growth in the region [3] Industry Engagement - LEEF will participate in the Benzinga Cannabis Capital Conference in Chicago on June 9-10, 2025, to connect with investors and industry leaders [5][6] - The executive team aims to build partnerships and share the company's growth story at the conference [7]